Accuray Stock Price. Everything You Need To Know About The Accuray Stock!
Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 1,044 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
Accuray Stock Price. Everything You Need To Know About The Accuray Stock! performance
- Employees 1044
- Company HQ Sunnyvale
- Website http://www.accuray.com/
- ARAY Asset Type Common Stock
- ARAY Market Capitalization 220.2M
- Earnings Per Share -0.15
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.962
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the US stock market? Look no further than Accuray, a leading name in the healthcare industry. Accuray specializes in developing and providing innovative, non-invasive treatment solutions for cancer patients. Investing in Accuray can be a smart move for several reasons. Firstly, the demand for effective cancer treatment options is continually growing, presenting a lucrative opportunity for investors. Secondly, Accuray has a proven track record of success, with its cutting-edge technologies used by medical professionals around the world. To invest in Accuray, retail investors from Malaysia, Thailand, Indonesia, and Vietnam can utilize Zorion’s investment platform. With Zorion, you can access real-time investment insights and recommendations to make informed decisions. Additionally, Zorion offers educational materials and resources to help expand your investment knowledge. Start investing in Accuray today and be a part of the future of cancer treatment.
